Solicitation of Nominations for Appointment to the Safety and Occupational Health Study Section, 48029-48030 [2022-16807]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 150 / Friday, August 5, 2022 / Notices
Dates: October 4–5, 2022.
Times: 11:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
Study Section to consider safety and
occupational health-related grant
applications.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific
Review Officer, NIOSH, 1095
Willowdale Road, Morgantown, West
Virginia 26506; Telephone: (304) 285–
5951; Email: MGoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–16806 Filed 8–4–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee
AGENCY:
Public Participation
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by the
number of audio and web conference
lines (300 audio and web conference
lines are available). Time will be
available for public comment.
Registration is required.
DATES: The meeting will be held on
August 23, 2022, from 12:00 p.m. to 2:00
p.m., EDT.
ADDRESSES: To register for this web
conference, please go to: www.cdc.gov/
hicpac. All registered participants will
receive the meeting link and
instructions shortly before the meeting.
Oral Public Comment: Time will be
available for public comment. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments.
Written Public Comment: The public
may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is August 15, 2022. All
requests must contain the submitter’s
name, address, and organizational
affiliation, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Please click the link below to join the
webinar: https://cdc.zoomgov.com/j/
1601692544?pwd=c0tVaHJoVUZSdHJx
TGppWVFiUHNidz09.
Meeting ID: 160 169 2544
Passcode: 07051018
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality
Promotion (DHQP), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), CDC, 1600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027; Telephone: (404)
718–8039; Email: HICPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, DHQP; the Director,
NCEZID; the Director, CDC; and the
Secretary, Department of Health and
Human Services, regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; Isolation Precautions
Guideline Workgroup; Neonatal
Intensive Care Unit Guideline
Workgroup; and Neonatal Pediatric
Surveillance Workgroup. Agenda items
are subject to change as priorities
dictate.
VerDate Sep<11>2014
17:20 Aug 04, 2022
Jkt 256001
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
48029
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–16805 Filed 8–4–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Safety and
Occupational Health Study Section
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
Safety and Occupational Health Study
Section (SOHSS). The SOHSS consists
of 20 experts in fields associated with
occupational medicine and nursing,
industrial hygiene, occupational safety
and engineering, toxicology, chemistry,
safety and health education,
ergonomics, epidemiology, economic
science, psychology, pulmonary
pathology/physiology, and social
science.
DATES: Nominations for membership on
the SOHSS must be received no later
than September 1, 2022. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to Dr. Michael Goldcamp,
National Institute for Occupational
Safety and Health, CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26506, or emailed
(recommended) to MGoldcamp@
cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific
Review Officer, National Institute for
Occupational Safety and Health, CDC,
1095 Willowdale Road, Morgantown,
West Virginia 26506; Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are being sought for
SUMMARY:
E:\FR\FM\05AUN1.SGM
05AUN1
lotter on DSK11XQN23PROD with NOTICES1
48030
Federal Register / Vol. 87, No. 150 / Friday, August 5, 2022 / Notices
individuals who have the expertise and
qualifications necessary to contribute to
the accomplishment of the Study
Section’s objectives. Nominees will be
selected based on expertise in the fields
of occupational medicine and nursing,
industrial hygiene, occupational safety
and engineering, toxicology, chemistry,
safety and health education,
ergonomics, epidemiology, economic
science, psychology, pulmonary
pathology/physiology, and social
science. Federal employees will not be
considered for membership. Members
may be invited to serve for up to fouryear terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of SOHSS
objectives.
The U.S. Department of Health and
Human Services (HHS) policy stipulates
that committee membership be balanced
in terms of points of view represented,
and the Study Section’s function.
Appointments shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
gender identity, HIV status, disability,
and cultural, religious, or
socioeconomic status. Nominees must
be U.S. citizens and cannot be full-time
employees of the U.S. Government.
Current participation on federal
workgroups or prior experience serving
on a federal advisory committee does
not disqualify a candidate; however,
HHS policy is to avoid excessive
individual service on advisory
committees and multiple committee
memberships. CDC reviews potential
candidates for SOHSS membership each
year and provides a slate of nominees
for consideration to the Secretary of
HHS for final selection. HHS notifies
selected candidates of their
appointment near the start of the term
in October 2023, or as soon as the HHS
selection process is completed. Note
that the need for different expertise
varies from year to year and a candidate
who is not selected in one year may be
reconsidered in a subsequent year.
Candidates should submit the following
items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services. Candidates
may submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (e.g., CDC,
NIH, FDA).
VerDate Sep<11>2014
17:20 Aug 04, 2022
Jkt 256001
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–16807 Filed 8–4–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10003, CMS–
1771, CMS–R–244 and CMS–10744]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
October 4, 2022.
SUMMARY:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10003—Notice of Denial of
Medical Coverage (or Payment)
CMS–1771—Emergency and Foreign
Hospital Services and Supporting
Regulation in 42 CFR Section 424.103
CMS–R–244—Programs of All-Inclusive
Care for the Elderly (PACE)
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
E:\FR\FM\05AUN1.SGM
05AUN1
]]>Agencies
[Federal Register Volume 87, Number 150 (Friday, August 5, 2022)]
[Notices]
[Pages 48029-48030]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16807]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Safety and
Occupational Health Study Section
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the Safety and Occupational
Health Study Section (SOHSS). The SOHSS consists of 20 experts in
fields associated with occupational medicine and nursing, industrial
hygiene, occupational safety and engineering, toxicology, chemistry,
safety and health education, ergonomics, epidemiology, economic
science, psychology, pulmonary pathology/physiology, and social
science.
DATES: Nominations for membership on the SOHSS must be received no
later than September 1, 2022. Packages received after this time will
not be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Dr. Michael Goldcamp,
National Institute for Occupational Safety and Health, CDC, 1095
Willowdale Road, Morgantown, West Virginia 26506, or emailed
(recommended) to [email protected].
FOR FURTHER INFORMATION CONTACT: Michael Goldcamp, Ph.D., Scientific
Review Officer, National Institute for Occupational Safety and Health,
CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506; Telephone:
(304) 285-5951; Email: [email protected].
SUPPLEMENTARY INFORMATION: Nominations are being sought for
[[Page 48030]]
individuals who have the expertise and qualifications necessary to
contribute to the accomplishment of the Study Section's objectives.
Nominees will be selected based on expertise in the fields of
occupational medicine and nursing, industrial hygiene, occupational
safety and engineering, toxicology, chemistry, safety and health
education, ergonomics, epidemiology, economic science, psychology,
pulmonary pathology/physiology, and social science. Federal employees
will not be considered for membership. Members may be invited to serve
for up to four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of SOHSS objectives.
The U.S. Department of Health and Human Services (HHS) policy
stipulates that committee membership be balanced in terms of points of
view represented, and the Study Section's function. Appointments shall
be made without discrimination on the basis of age, race, ethnicity,
gender, sexual orientation, gender identity, HIV status, disability,
and cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. CDC reviews
potential candidates for SOHSS membership each year and provides a
slate of nominees for consideration to the Secretary of HHS for final
selection. HHS notifies selected candidates of their appointment near
the start of the term in October 2023, or as soon as the HHS selection
process is completed. Note that the need for different expertise varies
from year to year and a candidate who is not selected in one year may
be reconsidered in a subsequent year. Candidates should submit the
following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-16807 Filed 8-4-22; 8:45 am]
BILLING CODE 4163-18-P
